Add BrightSurf on Google Email

Heart failure: The Alzheimer's disease of the heart?

Researchers have identified protein clumping in the hearts of mice and people with heart failure, suggesting a potential link between the two conditions. The team used non-invasive PET scans to visualize the clumps, which could lead to advances in monitoring disease progression and testing new therapies.

SourceJohns Hopkins Medicine·JournalCirculation Research·DateMay 9, 2018

First ever risk tool predicts readmission rates for patients after undergoing TAVR

A new study developed a novel risk tool to predict 30-day readmission rates in patients undergoing transcatheter aortic valve replacement (TAVR). The tool calculates a score based on several variables, including chronic kidney disease, anemia, and discharge disposition, with a c-statistic of 0.63.

SourceSociety for Cardiovascular Angiography and Interventions·JournalCatheterization and Cardiovascular Interventions·DateApr 27, 2018

Contemporary update to PROGRESS-CTO International Registry shows successful outcomes

A significant update to the PROGRESS-CTO International Registry reveals successful outcomes of Chronic Total Occlusion Percutaneous Intervention (CTO PCI) for over 3,000 patients. The study found high success rates with acceptable complications, supporting its use in experienced centers.

SourceSociety for Cardiovascular Angiography and Interventions·JournalCatheterization and Cardiovascular Interventions·DateApr 27, 2018

New study shows length of hospital stay impacts outcomes after TAVR procedure

A new study has found that patients who undergo TAVR procedure and stay in the hospital for more than 72 hours may be at risk of negative short and long-term outcomes. The study identified independent predictors of both early and delayed discharge, with delayed discharge associated with worse one-year outcomes.

SourceSociety for Cardiovascular Angiography and Interventions·JournalCatheterization and Cardiovascular Interventions·DateApr 26, 2018

Solo medical practices outperform groups in treatment of cardiac disease

A recent study by Donna Shelley et al found that small urban primary care practices consistently meet or exceed Million Hearts goals for cardiovascular disease care. However, these practices struggle to achieve clinical targets for patients with multiple risk factors, highlighting the need for support in managing complex cases.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateApr 9, 2018

Study: Medicaid expansion has no negative effect on cardiovascular procedural outcomes

A recent study published in the Journal of the American College of Cardiology found that Medicaid expansion in Michigan did not negatively impact patient outcomes for coronary artery disease procedures. The research used data from 7,558 CABG procedures and 45,183 PCI procedures performed at various hospitals across the state.

SourceMichigan Medicine - University of Michigan·JournalJournal of the American College of Cardiology·DateApr 9, 2018

CNIC scientists identify a promising target for the treatment of heart failure

Researchers have identified a new therapeutic target, OMA1, which protects cardiomyocytes from death and deterioration in heart function when the heart is under stress. Inhibition of OMA1 prevents heart failure in models of chronic tachycardia, hypertension, and myocardial ischemia with cardiac hypertrophy.

Can a smartwatch detect irregular heartbeat?

A smartwatch coupled with a machine learning algorithm detected atrial fibrillation (AF) with high accuracy in patients undergoing treatment for AF. The study used data from 9,750 participants and found promising results for the use of commercially available smartwatches to detect AF.

SourceJAMA Network·JournalJAMA Cardiology·DateMar 21, 2018

Trial shows safety of drugs for irregular heartbeat patients undergoing treatment

Atrial fibrillation affects millions worldwide, increasing risk of stroke and heart failure. A new study finds Apixaban and VKAs safe for treatment during catheter ablation procedures, with a significant improvement in cognitive function. The results will reassure clinicians that continuous Apixaban is an effective alternative to VKAs.

SourceUniversity of Birmingham·JournalEuropean Heart Journal·DateMar 20, 2018

Potential RNA Markers of abnormal heart rhythms identified in circulating blood

A study published in Circulation Journal identified four microRNA molecules in the bloodstream that could predict the onset of atrial fibrillation. The researchers found that these microRNAs were significantly upregulated in the serum of patients with AF and diseased mice, suggesting their potential use as biomarkers for disease.

SourceTokyo Medical and Dental University·JournalCirculation Journal·DateMar 15, 2018

Patients with kidney disease with heart defibrillators at greater risk of hospitalization

A study by Kaiser Permanente and University of Washington found that patients with chronic kidney disease who receive implantable cardioverter defibrillators experience a significantly increased risk of subsequent hospitalization. The use of ICDs was associated with a 49% increased risk of hospitalization for heart failure and a 25% in...

SourceKaiser Permanente·JournalJAMA Internal Medicine·DateFeb 5, 2018

Spinal cord injury affects the heart

Research published in Experimental Physiology found that spinal cord injury affects the heart, with changes dependent on injury severity. The study suggests preserving more nerve fibers can improve heart function in individuals with spinal cord injury, who are at higher risk of heart disease.

SourceThe Physiological Society·JournalExperimental Physiology·DateDec 12, 2017

Children with heart disease are being let down by lack of clinical trials, study finds

A UK study found that less than one per cent of children born with congenital heart disease participate in clinical trials, highlighting a need for improved treatment options. Researchers suggest establishing a congenital heart disease research network to conduct well-designed clinical trials and improve surgical outcomes.

SourceUniversity of Birmingham·JournalEuropean Journal of Cardio-Thoracic Surgery·DateNov 22, 2017

Drug could cut transplant rejection

A diabetes drug that increases the movement of regulatory T cells into human organs may help prevent transplant rejection without side effects. Researchers found that the enzyme glucokinase is linked to increased movement of these immune cells, which act as guardians against organ rejection.

SourceQueen Mary University of London·JournalImmunity·DateNov 21, 2017